Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $250.40M.
ENTERPRISE VALUE (EV)
$250.40M
Sagimet Biosciences Inc.
Market Cap
$285.42M
Enterprise Value (EV)
$250.40M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Sagimet Biosciences Inc. (SGMT) | $285.42M | $250.40M |
| Abeona Therapeutics Inc. (ABEO)vs › | $285.55M | $249.19M |
| Aurora Cannabis Inc. (ACB)vs › | $284.31M | $216.91M |
| Standard BioTools Inc. (LAB)vs › | $282.64M | $40.70M |
| Larimar Therapeutics, Inc. (LRMR)vs › | $288.79M | $201.06M |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $281.54M | $238.35M |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $280.37M | $228.83M |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $292.59M | $123.93M |
| Indaptus Therapeutics, Inc. (INDP)vs › | $293.30M | $285.74M |
| Vanda Pharmaceuticals Inc. (VNDA)vs › | $271.81M | $238.76M |
Market Cap
$285.42M
Total Debt
$0.00
Cash
$35.02M
Enterprise Value
$250.40M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
